{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:18:42Z","timestamp":1762100322735},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1993,5,1]],"date-time":"1993-05-01T00:00:00Z","timestamp":736214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[1993,5]]},"DOI":"10.1007\/bf01212721","type":"journal-article","created":{"date-parts":[[2005,2,25]],"date-time":"2005-02-25T11:56:28Z","timestamp":1109332588000},"page":"257-259","source":"Crossref","is-referenced-by-count":18,"title":["Radioimmunotherapy for unresectable hepatocellular carcinoma using131I-Hepama-1 mAb: preliminary results"],"prefix":"10.1007","volume":"119","author":[{"given":"Zhao-Chong","family":"Zeng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao-You","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang-Da","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Zen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Jie","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gen-Fen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zen","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-mo","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3233\/HAB-1991-2103","volume":"2","author":"HM Blottiere","year":"1991","unstructured":"Blottiere HM, Steplewski Z, Herlyn D, Douillard JY (1991) Human anti-murine immunoglobulin responses and immune functions in cancer patients receiving murine monoclonal antibody therapy. Hum Antibodies Hybridomas 2:16?25","journal-title":"Hum Antibodies Hybridomas"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1089\/sct.1991.7.9","volume":"7","author":"RD Blumenthal","year":"1991","unstructured":"Blumenthal RD, Sharkey RM, Kashi R, Goldenberg DM (1991) Suppression of tumor vascular activity by radioantibody therapy: implications for multiple cycle treatments. Sel Cancer Ther 7:9?16","journal-title":"Sel Cancer Ther"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF01294442","volume":"118","author":"Z Fan","year":"1992","unstructured":"Fan Z, Tang ZY, Liu KD, Zhou D, Lu JZ, Yuan AN, Zhao HY (1992) Radioiodinated anti-hepatocellular carcinoma (HCC) ferritin: targeting therapy, tumor imaging and anti-antibody response in HCC patients with hepatic arterial infusion. J Cancer Res Clin Oncol 118:371?376","journal-title":"J Cancer Res Clin Oncol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0090-8258(90)90049-Q","volume":"38","author":"MG Muto","year":"1990","unstructured":"Muto MG, Finkler NJ, Kassis AI, Lepisto EM, Knapp RC (1990) Human anti-murine antibody responses in ovarian cancer patients undergoing radioimmunotherapy with the murine monoclonal antibody OD-125. Gynccol Oncol 38:244?248","journal-title":"Gynccol Oncol"},{"key":"CR5","first-page":"351","volume-title":"Selected methods in cellular immulogy","author":"VT Oi","year":"1980","unstructured":"Oi VT, Herzenbere LA (1980) Immunoglobulin producing hybrid cell lines. In: Mishell BB, Shiigi SM (eds) Selected methods in cellular immulogy. Freman, San Francisco, pp 351?372"},{"key":"CR6","first-page":"845","volume":"17","author":"D Pressman","year":"1957","unstructured":"Pressman D, Day ED, Blau M (1957) The use of paired labeling in the determination of tumor-localizing antibodies. Cancer Res 17:845?850","journal-title":"Cancer Res"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/1097-0142(19900115)65:2<211::AID-CNCR2820650205>3.0.CO;2-G","volume":"65","author":"ZY Tang","year":"1990","unstructured":"Tang ZY, Liu KD, Bao YM, Lu JZ, Qian F, Yuan AN, Zhao HY (1990) Radioimmunotherapy in the multimodality treatment of hepatocellular carcinoma with reference to second-look resection. Cancer 65:211?215","journal-title":"Cancer"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jso.2930470107","volume":"47","author":"ZY Tang","year":"1991","unstructured":"Tang ZY, Yu YQ, Zhou XD, Ma ZC, Lu JZ, Liu KD, Lin ZY, Yang BH, Fan Z, Hou Z (1991) Cytoreduction and sequential resection: a hope for unresectable primary liver cancer. J Surg Oncol 47:27?31","journal-title":"J Surg Oncol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1200\/JCO.1988.6.10.1636","volume":"6","author":"S Vadhan-Raj","year":"1988","unstructured":"Vadhan-Raj S, Cordon-Cardo C, Carswell E, Minrzer D, Dantis L, Duteau C, Templetton MA, Oettgen HF, Old LJ, Houghton AN (1988) Phase I trial of a mouse monoclonal antibody against GD3 ganglioside in patients with melanoma: induction of inflammatory responses at tumor sites. J Clin Oncol 6:1636?1648","journal-title":"J Clin Oncol"},{"key":"CR10","first-page":"363","volume":"18","author":"H Xie","year":"1985","unstructured":"Xie H, Yang ZH, Chen RM, Yao Z, Wang BM, Guo SY, Yan ZF (1985) Two mouse hybridomas secreting monoclonal antibodies against human liver carcinoma and their antibody specificity (in Chinese). Acta Biol Exp Sin 18:363?373","journal-title":"Acta Biol Exp Sin"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/00004728-198607000-00015","volume":"10","author":"NC Yang","year":"1986","unstructured":"Yang NC, Leichner PK, Fishman EK, Siegelman SS, Frenkel TL, Wallace JR, Loudenslager DM, Hawkins WG, Order SE (1986) CT volumetrics of primary liver cancers. J Comput Assist Tomogr 10:621?628","journal-title":"J Comput Assist Tomogr"},{"key":"CR12","first-page":"243","volume":"10","author":"YJ Zhang","year":"1991","unstructured":"Zhang YJ, Tang ZY, Xie H, Yao Z, Yuan AN, Zhao HY, Lu JZ (1991) Imaging and therapy of human hepatocellular carcinoma with radiolabeled monoclonal antibody. J Exp Clin Cancer Res 10:243?251","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01212721.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01212721\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01212721","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T05:47:08Z","timestamp":1556776028000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01212721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,5]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1993,5]]}},"alternative-id":["BF01212721"],"URL":"https:\/\/doi.org\/10.1007\/bf01212721","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,5]]}}}